438
Participants
Start Date
November 30, 2006
Primary Completion Date
June 30, 2011
Study Completion Date
July 31, 2025
recombinant thyroid-stimulating hormone
Recombinant thyroid stimulating hormone (rhTSH) should be given at a dose of 0.9mg by intramuscular injection on two consecutive days before ablation.
Radiodine ablation without rhTSH
Patients in this group do not receive rhTSH pre ablation.
Sussex Cancer Centre at Royal Sussex County Hospital, Brighton
Addenbrooke's Hospital, Cambridge
Kent and Canterbury Hospital, Canterbury
Castle Hill Hospital, Cottingham
Derbyshire Royal Infirmary, Derby
Royal Devon and Exeter Hospital, Exeter
Gloucestershire Royal Hospital, Gloucester
St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford
Ipswich Hospital, Ipswich
Leeds Cancer Centre at St. James's University Hospital, Leeds
Leicester Royal Infirmary, Leicester
Guy's Hospital, London
Royal Marsden - London, London
Maidstone Hospital, Maidstone
Christie Hospital, Manchester
James Cook University Hospital, Middlesbrough
Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne
Northampton General Hospital, Northampton
Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood
Norfolk and Norwich University Hospital, Norwich
Dorset Cancer Centre, Poole Dorset
Cancer Research Centre at Weston Park Hospital, Sheffield
University Hospital of North Staffordshire, Stoke-on-Trent
Velindre Cancer Center at Velindre Hospital, Cardiff
Glan Clwyd Hospital, Rhyl
University College, London
OTHER